Page last updated: 2024-11-08

steviol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

steviol: aglucon of stevioside; RN given refers to (4alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

steviol : An ent-kaurane diterpenoid that is 5beta,8alpha,9beta,10alpha-kaur-16-en-18-oic acid in which the hydrogen at position 13 has been replaced by a hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID452967
CHEMBL ID463996
CHEBI ID145024
SCHEMBL ID28608
MeSH IDM0058753

Synonyms (45)

Synonym
hydroxydehydrostevic acid
ccris 2588
kaur-16-en-18-oic acid, 13-hydroxy-, (14-alpha)-
(14-alpha)-13-hydroxykaur-16-en-18-oic acid
kaur-16-en-18-oic acid, 13-hydroxy-, (4alpha)-
nsc 226902
kaur-16-en-18-oic acid, 13-hydroxy-, (4.alpha.)-
steviol
NCGC00186036-01
CHEMBL463996
QFVOYBUQQBFCRH-VQSWZGCSSA-N
(-)-steviol
CHEBI:145024
13alpha-hydroxy-5beta,8alpha,9beta,10alpha-kaur-16-en-18-oic acid
HMS3263G10
C20212
S3272
4741lyx6rt ,
unii-4741lyx6rt
ent-13-hydroxy-kauran-16-en-19-oic acid
13-hydroxykaurenoic acid
steviol hydrate
LP01074
stevioside aglycon
steviol [mi]
rebaudiosides aglycon
(4.alpha.)-13-hydroxykaur-16-en-18-oic acid
CCG-222378
SCHEMBL28608
NCGC00261759-01
tox21_501074
(4r)-13-hydroxykaur-16-en-18-oic acid
mfcd00210558
steviol, analytical standard
bdbm50480263
(4r,4as,6ar,9s,11ar,11bs)-9-hydroxy-4,11b-dimethyl-8-methylenetetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylic acid
AKOS037514919
DTXSID50897427
HY-N2057
Q426852
SDCCGSBI-0633785.P001
NCGC00186036-04
CS-0018546
steviol (hydroxydehydrostevic acid)
(1r,4s,5r,9s,10r,13s)-13-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylic acid

Research Excerpts

Toxicity

LD50 values of Steviol in hamsters were 5. In light of the obtained results, the presumably safe profile of known compounds, such as the case of steviol (1), is critically discussed.

ExcerptReferenceRelevance
"0 g/kg BW/day were highly toxic to both dams and fetuses."( Developmental toxicity of steviol, a metabolite of stevioside, in the hamster.
Glinsukon, T; Mungkornkarn, P; Suttajit, M; Temcharoen, P; Toskulkao, C; Wasuntarawat, C, 1998
)
0.3
" Neither stevia manufacturers nor food allergy networks have reported significant numbers of any adverse events related to ingestion of stevia-based sweeteners, and there have been no reports of stevia-related allergy in the literature since 2008."( Steviol glycoside safety: are highly purified steviol glycoside sweeteners food allergens?
Carakostas, MC; Taylor, SL; Urban, JD, 2015
)
0.42
" In light of the obtained results, the presumably safe profile of known compounds, such as the case of steviol (1), is critically discussed."( Inverse Virtual Screening for the rapid re-evaluation of the presumed biological safe profile of natural products. The case of steviol from Stevia rebaudiana glycosides on farnesoid X receptor (FXR).
Bifulco, G; Carino, A; Cavalluzzi, MM; Fiorucci, S; Lauro, G; Lentini, G; Milani, G; Pierri, CL; Potenza, M; Roselli, R; Zampella, A, 2021
)
0.62

Pharmacokinetics

ExcerptReferenceRelevance
" In addition, co-administration of rebaudioside A with repaglinide in rats did not lead to AUC and Cmax changes of repaglinide."( CYP2C8-mediated interaction between repaglinide and steviol acyl glucuronide: In vitro investigations using rat and human matrices and in vivo pharmacokinetic evaluation in rats.
Li, J; Lu, J; Wang, M; Wang, Y; Xu, Y; Zhang, H; Zhou, D, 2016
)
0.43
" We aimed to characterize the pharmacokinetic and pharmacodynamic properties of rebaudioside A and its metabolites in patients with early-onset type 2 diabetes mellitus (T2DM)."( Pharmacokinetics of Oral Rebaudioside A in Patients with Type 2 Diabetes Mellitus and Its Effects on Glucose Homeostasis: A Placebo-Controlled Crossover Trial.
Ampe, E; Billen, J; de Hoon, J; Goscinny, S; Mertens, A; Philippaert, K; Simoens, C; Van der Schueren, B; Van Hoeck, E; Van Loco, J; Vangoitsenhoven, R; Vennekens, R; Wuyts, C, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
" However, low aqueous solubility and consequent poor bioavailability of curcuminoids are major limitations to their use."( Facile preparation of water soluble curcuminoids extracted from turmeric (Curcuma longa L.) powder by using steviol glucosides.
Chung, B; Chung, D; Kang, C; Kim, D; Nguyen, TTH; Si, J, 2017
)
0.46

Dosage Studied

ExcerptRelevanceReference
" A double-blind, randomized crossover dose-response study was conducted to assess the usefulness of urinary LCS excretions (from both fasting spot and a full 24-h urine collection) for investigating recent intakes."( Application of Liquid Chromatography-Tandem Mass Spectrometry To Determine Urinary Concentrations of Five Commonly Used Low-Calorie Sweeteners: A Novel Biomarker Approach for Assessing Recent Intakes?
Dowey, LRC; Gallagher, AM; Logue, C; McClean, S; Strain, JJ; Verhagen, H, 2017
)
0.46
" The production of steviol glycosides presented a biphasic dose-response suggestive of hormesis, with the highest values at 10 mg/L PSNPs (1."( Effects of polystyrene nanoplastics exposure on in vitro-grown Stevia rebaudiana plants.
Clapa, D; Coman, C; Coman, V; Iancu, ȘD; Leopold, LF; Leopold, N; Scurtu, VF, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
tetracyclic diterpenoidA diterpenoid with a tetracyclic skeleton.
tertiary allylic alcoholAn allylic alcohol in which the carbon atom that links the double bond to the hydroxy group is also attached to two other carbons (R4,R5 =/= H).
monocarboxylic acidAn oxoacid containing a single carboxy group.
bridged compoundA polycyclic compound in which two rings have two or more atoms in common.
ent-kaurane diterpenoidA diterpenoid compound having an ent-kaurane skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency31.62280.035520.977089.1251AID504332
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (65)

Assay IDTitleYearJournalArticle
AID1406745Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification.
AID1870852Antiproliferative activity against human HCT-116 cells measured after 48 hrs by CCK8 assay
AID1431323Selectivity index, ratio of TC50 for human HuH7 cells to IC50 for Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of HBeAg secretion2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Synthesis of C-4-Substituted Steviol Derivatives and Their Inhibitory Effects against Hepatitis B Virus.
AID348201Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 20 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID1870855Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by CCK8 assay
AID348198Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 20 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID1870851Cytotoxicity against human MCF7 cells assessed as cell viability after 48 hrs by inverted-phase contrast microscopy
AID1431319Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of HBsAg secretion by EIA2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Synthesis of C-4-Substituted Steviol Derivatives and Their Inhibitory Effects against Hepatitis B Virus.
AID357845Binding affinity to calf thymus DNA assessed as reduction in DNA peak by pre-incubation method
AID348189Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 100 mol ratio after 48hrs by indirect immunofluorescence technique relative to control2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID1870854Antiproliferative activity against human Huh-7 cells measured after 48 hrs by CCK8 assay
AID348192Cytotoxicity against human Raji cells assessed as cell viability at 1000 mol ratio by trypan blue staining2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID348208Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 20 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID1870853Antiproliferative activity against human HeLa cells measured after 48 hrs by CCK8 assay
AID379153Agonist activity at glucocorticoid receptor transfected in mouse RAW264.7 cells assessed as firefly/renilla luciferase ratio at 10 uM by dual liciferase reporter assay2006Journal of natural products, Oct, Volume: 69, Issue:10
Transformation of steviol-16alpha,17-epoxide by Streptomyces griseus and Cunninghamella bainieri.
AID348197Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID348207Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID348190Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 10 mol ratio after 48hrs by indirect immunofluorescence technique relative to control2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID348202Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 10 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID551372Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Synthesis and biological evaluation of novel exo-methylene cyclopentanone tetracyclic diterpenoids as antitumor agents.
AID348199Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 10 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID348209Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 10 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID1431320Cytotoxicity against human HuH7 cells assessed as reduction in cell viability after 3 days by MTS assay2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Synthesis of C-4-Substituted Steviol Derivatives and Their Inhibitory Effects against Hepatitis B Virus.
AID348193Cytotoxicity against human Raji cells assessed as cell viability at 500 mol ratio by trypan blue staining2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID348191Inhibition of TPA-induced EBV-early antigen activation in human Raji cells after 48hrs by indirect immunofluorescence technique2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID357846Binding affinity to yeast tRNA assessed as reduction in tRNA peak by pre-incubation method
AID348194Cytotoxicity against human Raji cells assessed as cell viability at 100 mol ratio by trypan blue staining2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID1431321Selectivity index, ratio of TC50 for human HuH7 cells to IC50 for Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of HBsAg secretion2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Synthesis of C-4-Substituted Steviol Derivatives and Their Inhibitory Effects against Hepatitis B Virus.
AID348200Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as number of skin papillomas per mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID1431325Selectivity index, ratio of TC50 for human HuH7 cells to IC50 for Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of viral DNA replication2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Synthesis of C-4-Substituted Steviol Derivatives and Their Inhibitory Effects against Hepatitis B Virus.
AID1870850Antiproliferative activity human against A549 cells measured after 48 hrs by CCK8 assay
AID397122Inhibition of HIV1 RT
AID348187Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 1000 mol ratio after 48hrs by indirect immunofluorescence technique relative to control2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID348210Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 10 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID1431322Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of HBeAg secretion by EIA2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Synthesis of C-4-Substituted Steviol Derivatives and Their Inhibitory Effects against Hepatitis B Virus.
AID348205Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 20 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID348188Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 500 mol ratio after 48hrs by indirect immunofluorescence technique relative to control2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID1152391Agonist activity at human RARalpha expressed in HEK293 cells assessed as transcriptional activation at 0.1 to 50 uM after 40 hrs by luciferase reporter gene assay2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Retinoic acid receptor agonist activity of naturally occurring diterpenes.
AID1431324Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of viral DNA replication by RT-PCR method2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Synthesis of C-4-Substituted Steviol Derivatives and Their Inhibitory Effects against Hepatitis B Virus.
AID1870856Antiproliferative activity against human HHL5 cells measured after 48 hrs by CCK8 assay
AID551370Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Synthesis and biological evaluation of novel exo-methylene cyclopentanone tetracyclic diterpenoids as antitumor agents.
AID551371Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Synthesis and biological evaluation of novel exo-methylene cyclopentanone tetracyclic diterpenoids as antitumor agents.
AID348204Inhibition of peroxynitrite-induced/TPA-promoted carcinogenesis in Sencar mouse assessed as reduction in skin papillomas bearing mouse at 85 nmol administered 1 hr before TPA treatment measured after 15 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID348195Cytotoxicity against human Raji cells assessed as cell viability at 10 mol ratio by trypan blue staining2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID348211Reduction in peroxynitrite-induced/TPA-promoted number of skin papillomas in Sencar mouse after 20 weeks2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (248)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (2.82)18.7374
1990's13 (5.24)18.2507
2000's44 (17.74)29.6817
2010's133 (53.63)24.3611
2020's51 (20.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.79%)5.53%
Reviews14 (5.53%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other237 (93.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]